July 18, 2019
Elanco collaborates with AgBiome for swine nutritional health innovation
Elanco Animal Health Incorporated (NYSE: ELAN) announced last month a new global R&D collaboration with AgBiome, Inc. to develop nutritional health products for swine.
The collaboration further demonstrates Elanco's commitment to antibiotic stewardship and bringing alternatives to producers' most difficult challenges.
The R&D collaboration with AgBiome is intended to deliver innovative probiotic solutions to some of swine producers' greatest gut health challenges. The collaboration will leverage AgBiome's proprietary strain identification system and provide Elanco access to AgBiome's extensive and growing collection of bacteria, viral and fungal strains. Elanco will combine AgBiome's success in crop science with its expertise in animal health. Terms of the deal were not disclosed.
"AgBiome's vast strain library and unique knowledge and methods for strain identification and development are particularly interesting to Elanco," said Aaron Schacht, executive vice president of Innovation, Regulatory and Business Development at Elanco. "Identifying and developing new products and tools to help manage the animal's microbiome, control infections, and reduce gut inflammation, while decreasing the need for medically important antibiotics is a top priority for Elanco."
"We are excited to be creating novel products for animal nutrition using the microbial technology and data science tools in our GenesisTM platform," said Eric Ward, co-CEO of AgBiome.
Elanco is committed to bringing greater clarity and collaboration to issues around antibiotic stewardship. The company released a multi-faceted 8-point Antibiotic Stewardship Plan in 2015 that includes 1) increasing responsible antibiotic use; 2) reducing the need for shared-class antibiotics; and 3) replacing antibiotics with alternatives to help livestock producers treat and prevent animal disease. The plan includes a commitment to deliver antibiotic alternatives, such as vaccines, enzymes and probiotics.